News | Endovascular Aortic Repair | July 02, 2015

Medtronic Acquires Aptus Endosystems

Aptus’ helical anchor technology complements Medtronic’s aortic stent platform for the treatment of complex aortic disease

Aptus Endosystems, Medtronic, acquisition, Heli-FX, Thoracic EndoAnchor, EVAR

Heli-FX image courtesy of Aptus Endosystems

July 2, 2015 - Medtronic plc announced it has acquired the assets of Aptus Endosystems Inc., a privately held medical device company focused on developing advanced technology for endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR). Medtronic completed its acquisition of the assets of Aptus Endosystems in a transaction valued at approximately $110 million. Additional terms of the acquisition were not disclosed.

Aptus Endosystems' Heli-FX and Heli-FX Thoracic EndoAnchor systems feature an endovascular-deployed anchor designed to attach a variety of aortic endografts to the native vessel wall. This off-the-shelf, customized solution minimizes the need for complicated procedures for the select subset of patients who would benefit from supplementary fixation. This may include patients with challenging anatomies, risk factors for a secondary intervention and existing seal complications, as well as in situations where a physician may intraoperatively determine the need for additional security.

The Heli-FX and Heli-FX Thoracic EndoAnchor systems bear the CE Mark for distribution in the European Union and are cleared by the U.S. Food and Drug Administration (FDA) for distribution in the United States. Both devices can be used with a wide variety of commercially available stent grafts, including Medtronic's Endurant and Valiant stent graft systems.

As part of the acquisition, Medtronic will also distribute the TourGuide Steerable Sheath, a device with adjustable tip that enables quick access and delivery of peripheral vascular products to the most challenging anatomy, in the United States and Europe.

Medtronic will continue the ANCHOR Registry - a global, multi-center, prospective post-market registry evaluating the Heli-FX Aortic Securement System. The company also plans to pursue approval for <10mm infrarenal proximal neck indication for Endurant with the use of the Heli-FX EndoAnchor system. 

Medtronic will report the Aptus business as part of its Aortic and Peripheral Vascular division within the Cardiac and Vascular Group. The transaction is expected to meet Medtronic's long-term financial metrics for acquisitions, and the annualized earnings impact of this acquisition is not expected to be material.

For more information: www.medtronic.com

Related Content

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Gore Announces First-in-Human Use of Gore TAG Conformable Thoracic Stent Graft
News | Stent Grafts| July 17, 2017
W. L. Gore & Associates Inc. announced the first patient implant of the Gore TAG Conformable Thoracic Stent Graft...
New Paper Highlights Success of Advanced Treatments in Complex Aortic Aneurysm Repair
News | Endovascular Aortic Repair| May 23, 2017
Significant success has been achieved in treating complex proximal aneurysms using a combination of fenestrated and...
News | Stent Grafts| April 06, 2017
Endologix Inc. announced that the first patients were treated in the Expanding Patient Applicability with Polymer...
abdominal aortic aneurysm, AAA, gender differences, women vs. men, endovascular repair, Journal of Vascular Surgery study
News | Endovascular Aortic Repair| April 05, 2017
Following repair of abdominal aortic aneurysms (AAA), women appear to have more unfavorable outcomes than men in terms...
Gore, Viabahn VBX Balloon Expandable Endoprosthesis, stent graft, iliac artery, FDA approval
Technology | Stent Grafts| January 31, 2017
W. L. Gore & Associates (Gore) announced that the Gore Viabahn VBX Balloon Expandable Endoprosthesis (VBX Stent...
Lombard Medical, Aorfix endovascular stent graft, Japanese regulatory approval, IntellFlex LP Delivery System
News | Stent Grafts| January 11, 2017
January 11, 2017 — Lombard Medical Inc.
stent grafts, fluid flow model, clotting risk, Journal of Vascular Surgery

An anterior view is shown of the geometries of each of the graft configurations: (A) fenestrated, (B) antegrade branched, (C) retrograde branched, and (D) manifold stent graft. Image courtesy of Taylor Suess, et al.

News | Stent Grafts| January 05, 2017
January 5, 2017 — Whether patients with mechanical heart valves and stents must take blood thinners depends on how ef
Sponsored Content | Videos | Artificial Intelligence| December 19, 2016
At RSNA 2016, the key buzzwords were “deep learning,” “machine learning” and “artificial intelligence.” Vendors and m
News | Stent Grafts| December 13, 2016
Lombard Medical Inc. announced that its Altura endovascular stent graft system was featured in a scientific...
Overlay Init